(Q36659385)

15 August 2017

Randomized trial of minocycline in the treatment of HIV-associated cognitive impairment (English)

1 reference

15 August 2017

1 reference

cognitive dysfunction

1 reference

Allan Ronald

8

0 references

Elly Katabira

6

object named as

Elly Katabira

1 reference

15 August 2017

5

Seggane Musisi

1 reference

15 August 2017

1

Noeline Nakasujja

1 reference

15 August 2017

10

Ned Sacktor

1 reference

15 August 2017

Sachiko Miyahara

2

1 reference

15 August 2017

Scott Evans

3

1 reference

15 August 2017

Anthony Lee

4

1 reference

15 August 2017

Kevin Robertson

7

1 reference

15 August 2017

David B Clifford

9

1 reference

15 August 2017

language of work or name

English

0 references

publication date

26 December 2012

1 reference

15 August 2017

1 reference

15 August 2017

80

1 reference

15 August 2017

2

1 reference

15 August 2017

196-202

1 reference

Minocycline treatment for HIV-associated cognitive impairment: results from a randomized trial

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589188

Hepatitis C infection, Cognition, and inflammation in an Egyptian sample

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589188

Screening for hepatitis C among HIV positive patients at Mulago hospital in Uganda.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589188

Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589188

Chapter 12- Brain as an HIV sequestered site: Use of nanoparticles as a therapeutic option

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589188

Minocycline attenuates HIV infection and reactivation by suppressing cellular activation in human CD4+ T cells.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589188

Tuberculous meningitis in HIV-infected individuals

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589188

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589188

Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589188

Minocycline treatment in acute stroke: an open-label, evaluator-blinded study.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589188

Pattern of neuropsychological performance among HIV positive patients in Uganda

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589188

Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589188

Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589188

The International HIV Dementia Scale: a new rapid screening test for HIV dementia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589188

Neuroprotective and anti-human immunodeficiency virus activity of minocycline

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589188

The promise of minocycline in neurology.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589188

Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589188

Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589188

The tetracycline derivative minocycline differentially affects cytokine production by monocytes and T lymphocytes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589188

Minocycline: A review of its antibacterial and pharmacokinetic properties and therapeutic use

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589188

Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589188

Pilot study of minocycline in relapsing-remitting multiple sclerosis

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589188

The prevalence and incidence of neurocognitive impairment in the HAART era.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589188

A novel action of minocycline: inhibition of human immunodeficiency virus type 1 infection in microglia

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589188

Minocycline blocks nitric oxide-induced neurotoxicity by inhibition p38 MAP kinase in rat cerebellar granule neurons

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589188

Nutritional Contributions to the CNS Pathophysiology of HIV-1 Infection and Implications for Treatment

20 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23269596

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23269596

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1212/WNL.0B013E31827B9121

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

23269596

1 reference